Home / Blog
Knowledge &
industry insights
Industry news, regulatory updates, health education, and company announcements — everything you need to stay ahead in pharma and nutraceuticals.
The Next Frontier: How Postbiotics Are Redefining the Biotic Ingredient Market
Beyond live cultures and fermentable fibres, a new category is emerging that promises greater stability, shelf life, and regulatory simplicity. Our Chief Scientific Officer explores what postbiotics mean for formulators and the future of the supplement industry.
From our knowledge centre
The EU’s updated Novel Foods framework introduces new strain-level documentation requirements. Here’s your compliance checklist.
New clinical evidence links specific Lactobacillus and Bifidobacterium strains to measurable improvements in anxiety and cognitive performance.
Rising global demand, competitive manufacturing costs, and improved regulatory frameworks are accelerating India’s role as the world’s biotic ingredient supplier.
Not all prebiotics are created equal. This technical guide compares fermentation rates, tolerable doses, and ideal applications for the most common prebiotic fibres.
Our new logistics partnerships in Germany, the Netherlands, and Poland reduce average EU delivery times by 40%.
A comprehensive guide for domestic and international buyers on navigating India’s nutraceutical trade regulations, FSSAI requirements, and IEC documentation.
Science-backed
health guidance
Our science team distils the latest clinical evidence into practical, evidence-based guidance for health professionals, formulators, and wellness brands.
Clinical evidence supports 10–50 Billion CFU daily for general gut health maintenance in healthy adults. Strain selection matters more than CFU count alone.
Combining prebiotics (food for bacteria) with probiotics (live bacteria) in synbiotic formulations significantly improves probiotic survival and colonisation.
Begin Saccharomyces boulardii or multi-strain Lactobacillus supplementation alongside antibiotic courses to prevent antibiotic-associated diarrhoea.
Most live probiotic cultures require refrigeration at 2–8°C. Spore-forming strains (Bacillus spp.) are the exception — shelf-stable at room temperature.
Company updates & milestones
All 14 enzyme SKUs in the QualiActiv™ range have received JAKIM Halal certification, opening access to GCC, Malaysian, and Indonesian markets.
Qualibiotica successfully completed its annual ISO 9001:2015 re-certification audit with zero non-conformances.
Our domestic supply division has on-boarded 50+ new hospital and clinic accounts across Delhi, Maharashtra, and Karnataka.
Our US FDA Food Facility registration has been renewed, maintaining uninterrupted access to the North American market.
Educational resources
Deep-dive guides, technical primers, and free downloadable resources for life science professionals and healthcare buyers.
Our 48-page comprehensive guide covering strain selection, CFU targets, delivery formats, stability testing, and regulatory considerations.
Download Free PDF →Recorded 90-minute webinar with our Head of Regulatory Affairs covering EFSA Novel Food authorisation, dossier preparation, and common rejection pitfalls.
Watch Recording →A curated 6-part article series covering microbiome basics, clinical applications, diagnostic approaches, and the future of personalised nutrition.
Read Series →Our annual market intelligence report covering market size, growth drivers, key players, regulatory landscape, and opportunity analysis across 12 major markets.
Request Report →A practical explainer for procurement professionals: how to read, validate, and compare CoA documents for probiotic, prebiotic, and enzyme ingredients.
Read Guide →Country-by-country compliance requirements for biotic ingredient imports. Covers USA, EU, UK, Australia, Japan, India, and 6 additional export markets.
Download Checklist →Regulatory landscape updates
Key regulatory developments across our major export and domestic markets — summarised by our compliance team.
FSSAI has updated labelling and claims regulations for nutraceuticals, impacting domestic supplement brands and importers. Our team has updated all documentation accordingly.
The US FDA updated its guidance on substantiation of structure/function claims for dietary supplements, affecting probiotic and prebiotic product labelling standards.
Updated EFSA guidelines now require strain-level safety documentation for all novel probiotic submissions. Qualibiotica has full compliance documentation available.
The UK Food Standards Agency has introduced a simplified authorisation pathway for probiotic strains with an established history of safe use in EU/UK markets prior to 2020.
Therapeutic Goods Administration clarifies evidence requirements for specific health claims on probiotic complementary medicines.
The ASEAN harmonisation framework for health supplements now includes probiotic and prebiotic ingredients, simplifying multi-country registrations across the bloc.
Join 4,200+ industry
professionals
Get our monthly digest of pharma industry news, regulatory updates, new product launches, and exclusive educational content — delivered to your inbox.
No spam. Unsubscribe at any time. Read our Privacy Policy.